Stage IV Merkel Cell Carcinoma AJCC v7
3 clinical trials · Condition
◉ Watch Stage IV Merkel Cell Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma (NCT02584829) | Fred Hutchinson Cancer Center | 2015-11-06 |
| Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer (NCT02267603) | National Cancer Institute (NCI) | 2014-11-25 |
Track Stage IV Merkel Cell Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.